» Articles » PMID: 33109529

Survival Following Traumatic Brain Injury in Is Increased by Heterozygosity for a Mutation of the NF-κB Innate Immune Response Transcription Factor Relish

Overview
Journal Genetics
Specialty Genetics
Date 2020 Oct 28
PMID 33109529
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) pathologies are caused by primary and secondary injuries. Primary injuries result from physical damage to the brain, and secondary injuries arise from cellular responses to primary injuries. A characteristic cellular response is sustained activation of inflammatory pathways commonly mediated by nuclear factor-κB (NF-κB) transcription factors. Using a TBI model, we previously found that the main proximal transcriptional response to primary injuries is triggered by activation of Toll and Imd innate immune response pathways that engage NF-κB factors Dif and Relish (Rel), respectively. Here, we found by mass spectrometry that Rel protein level increased in fly heads at 4-8 hr after TBI. To investigate the necessity of Rel for secondary injuries, we generated a null allele, , by CRISPR/Cas9 editing. When heterozygous but not homozygous, the mutation reduced mortality at 24 hr after TBI and increased the lifespan of injured flies. Additionally, the effect of heterozygosity for on mortality was modulated by genetic background and diet. To identify genes that facilitate effects of on TBI outcomes, we compared genome-wide mRNA expression profiles of uninjured and injured +/+, +/ , and / flies at 4 hr following TBI. Only a few genes changed expression more than twofold in +/ flies relative to +/+ and / flies, and they were not canonical innate immune response genes. Therefore, Rel is necessary for TBI-induced secondary injuries but in complex ways involving gene dose, genetic background, diet, and possibly small changes in expression of innate immune response genes.

Citing Articles

A Pvr-AP-1-Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury.

Li T, Shi W, Ho M, Zhang Y Elife. 2024; 12.

PMID: 39480704 PMC: 11527428. DOI: 10.7554/eLife.87258.


Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration.

Lee S, Silverman N, Gao F Trends Neurosci. 2024; 47(11):949-961.

PMID: 39389804 PMC: 11563872. DOI: 10.1016/j.tins.2024.09.001.


Astrocytes, reactive astrogliosis, and glial scar formation in traumatic brain injury.

Cieri M, Ramos A Neural Regen Res. 2024; 20(4):973-989.

PMID: 38989932 PMC: 11438322. DOI: 10.4103/NRR.NRR-D-23-02091.


The NFκB Dif is required for behavioral and molecular correlates of sleep homeostasis in Drosophila.

OHara M, Saul C, Handa A, Cho B, Zheng X, Sehgal A Sleep. 2024; 47(8).

PMID: 38629438 PMC: 11321855. DOI: 10.1093/sleep/zsae096.


Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a Model of Huntington's Disease.

Davis G, Zaya A, Pearce M J Neurosci. 2024; 44(20).

PMID: 38589228 PMC: 11097281. DOI: 10.1523/JNEUROSCI.1256-23.2024.


References
1.
Sen A, Gurdziel K, Liu J, Qu W, Nuga O, Burl R . Smooth, an hnRNP-L Homolog, Might Decrease Mitochondrial Metabolism by Post-Transcriptional Regulation of Isocitrate Dehydrogenase (Idh) and Other Metabolic Genes in the Sub-Acute Phase of Traumatic Brain Injury. Front Genet. 2017; 8:175. PMC: 5694756. DOI: 10.3389/fgene.2017.00175. View

2.
Kurata S . Peptidoglycan recognition proteins in Drosophila immunity. Dev Comp Immunol. 2013; 42(1):36-41. PMC: 3808481. DOI: 10.1016/j.dci.2013.06.006. View

3.
Cinege G, Zsamboki J, Vidal-Quadras M, Uv A, Csordas G, Honti V . Genes encoding cuticular proteins are components of the Nimrod gene cluster in Drosophila. Insect Biochem Mol Biol. 2017; 87:45-54. DOI: 10.1016/j.ibmb.2017.06.006. View

4.
Hedengren M, Asling B, Dushay M, Ando I, Ekengren S, Wihlborg M . Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol Cell. 2000; 4(5):827-37. DOI: 10.1016/s1097-2765(00)80392-5. View

5.
Kleino A, Silverman N . The Drosophila IMD pathway in the activation of the humoral immune response. Dev Comp Immunol. 2013; 42(1):25-35. PMC: 3808521. DOI: 10.1016/j.dci.2013.05.014. View